Cargando…
The Immune Microenvironment in Penile Cancer and Rationale for Immunotherapy
Penile cancer is an extremely rare malignancy that accounts for approximately 1% of cancer deaths in the United States every year. While primary penile cancer can be managed surgically, advanced and metastatic forms of the disease require more aggressive management plans with systemic chemotherapy a...
Autores principales: | Ahmed, Mohamed E., Falasiri, Shayan, Hajiran, Ali, Chahoud, Jad, Spiess, Philippe E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603091/ https://www.ncbi.nlm.nih.gov/pubmed/33080912 http://dx.doi.org/10.3390/jcm9103334 |
Ejemplares similares
-
Prognostic predictors of lymph node metastasis in penile cancer: a systematic review
por: Zekan, David S., et al.
Publicado: (2021) -
An update on treatment of penile cancer
por: Chadha, Juskaran, et al.
Publicado: (2022) -
Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma
por: Chatwal, Monica Sheila, et al.
Publicado: (2023) -
Penile cancer: Updates in systemic therapy
por: Joshi, Vidhu B., et al.
Publicado: (2022) -
An Analysis of Nectin-4 (PVRL4) in Penile Squamous Cell Carcinoma
por: Grass, G.Daniel, et al.
Publicado: (2023)